Furthermore, DPPIV’s enzymatic role in degrading glucagon-like peptide-1 (GLP-1) links it to hyperglycemia, a significant risk factor for severe COVID-19 outcomes [74]. The gene discussed is DPP4; the disease is COVID-19.